U.S. federal trademark · Serial No. 86463066 · Reg. No. 4807093
Development of pharmaceutical preparations and medicines; Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical research services; development of pharmaceutical products to order and/or specification of others
Manufacture of pharmaceutical products to order and specification of others; Providing technical information in the field of pharmaceutical manufacturing
Pharmaceutical preparations for human and animal use for emergency treatment of allergic reactions, maintenance of mydriasis during intraocular surgery, vasoconstriction, nasal decongestion, detection of infection with mycobacterium tuberculosis, anesthesia, treatment of bacterial infections, controlling the manifestations of clinical spasticity resulting from upper motor neuron disorders, prevention, attenuation, or management of malignant hyperthermia, treatment of symptoms associated with menopause, treatment of hypoestrogenism, palliative treatment of advanced androgen-dependent carcinoma of the prostate, initiation or improvement of uterine contractions, treatment of postoperative nausea and vomiting or nausea associated with gastroenteritis, treatment of myxedema coma and pre-coma, increasing blood pressure in patients with vasodilatory shock, management of patients requiring prolonged parenteral neuroleptic therapy, treatment of hypercalcemia of malignancy, treatment of multiple myeloma, and treatment of patients with documented bone metastases from solid tumors
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.